Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A century of BCG: Impact on tuberculosis control and beyond.
Ahmed A, Rakshit S, Adiga V, Dias M, Dwarkanath P, D'Souza G, Vyakarnam A. Ahmed A, et al. Among authors: dias m. Immunol Rev. 2021 May;301(1):98-121. doi: 10.1111/imr.12968. Epub 2021 May 6. Immunol Rev. 2021. PMID: 33955564 Review.
BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD™ vaccine in SARS-CoV-2 seronegative young Indian adults.
Rakshit S, Adiga V, Ahmed A, Parthiban C, Kumar NC, Dwarkanath P, Shivalingaiah S, Rao S, D'Souza G, Dias M, Maguire TJA, Doores K, Dasgupta P, Babji S, Ottenhoff THM, Stuart KD, De Rosa S, McElrath MJ, Vyakarnam A. Rakshit S, et al. Among authors: dias m. Res Sq [Preprint]. 2022 Mar 2:rs.3.rs-1395683. doi: 10.21203/rs.3.rs-1395683/v1. Res Sq. 2022. PMID: 35262071 Free PMC article. Preprint.
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.
Rakshit S, Adiga V, Ahmed A, Parthiban C, Chetan Kumar N, Dwarkanath P, Shivalingaiah S, Rao S, D'Souza G, Dias M, Maguire TJA, Doores KJ, Zoodsma M, Geckin B, Dasgupta P, Babji S, van Meijgaarden KE, Joosten SA, Ottenhoff THM, Li Y, Netea MG, Stuart KD, De Rosa SC, McElrath MJ, Vyakarnam A. Rakshit S, et al. Among authors: dias m. Front Immunol. 2022 Oct 4;13:985938. doi: 10.3389/fimmu.2022.985938. eCollection 2022. Front Immunol. 2022. PMID: 36268023 Free PMC article.
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians.
Rakshit S, Babji S, Parthiban C, Madhavan R, Adiga V, J SE, Chetan Kumar N, Ahmed A, Shivalingaiah S, Shashikumar N, V M, Johnson AR, Ramesh N, B RG, Asokan M, Mayor S, Kang G, D'souza G, Dias M, Vyakarnam A. Rakshit S, et al. Among authors: dias m. NPJ Vaccines. 2023 Sep 14;8(1):134. doi: 10.1038/s41541-023-00731-w. NPJ Vaccines. 2023. PMID: 37709772 Free PMC article.
BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways.
Ahmed A, Tripathi H, van Meijgaarden KE, Kumar NC, Adiga V, Rakshit S, Parthiban C, Eveline J S, D'Souza G, Dias M, Ottenhoff THM, Netea MG, Joosten SA, Vyakarnam A. Ahmed A, et al. Among authors: dias m. iScience. 2023 Sep 9;26(10):107889. doi: 10.1016/j.isci.2023.107889. eCollection 2023 Oct 20. iScience. 2023. PMID: 37817935 Free PMC article.
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study.
Asokan MS, Joan RF, Babji S, Dayma G, Nadukkandy P, Subrahmanyam V, Pandey A, Malagi G, Arya P, Mahajan V, Bhavikatti J, Pawar K, Thorat A, Shah P, Goud RB, Roy B, Rajukutty S, Immanuel S, Agarwal D, Saha S, Shivaraj A, Panikulam P, Shome R, Gulzar SE, Sharma AU, Naik A, Talashi S, Belekar M, Yadav R, Khude P, V M, Shivalingaiah S, Deshmukh U, Bhise C, Joshi M, Inbaraj LR, Chandrasingh S, Ghose A, Jamora C, Karumbati AS, Sundaramurthy V, Johnson A, Ramesh N, Chetan N, Parthiban C, Ahmed A, Rakshit S, Adiga V, D'souza G, Rale V, George CE, John J, Kawade A, Chaturvedi A, Raghunathan A, Dias M, Bhosale A, Raghu P, Shashidhara LS, Vyakarnam A, Bal V, Kang G, Mayor S. Asokan MS, et al. Among authors: dias m. Lancet Reg Health Southeast Asia. 2024 Feb 27;22:100361. doi: 10.1016/j.lansea.2024.100361. eCollection 2024 Mar. Lancet Reg Health Southeast Asia. 2024. PMID: 38482152 Free PMC article.
Immune profiling reveals umbilical cord blood mononuclear cells from South India display an IL-8 dominant, CXCL-10 deficient polyfunctional monocyte response to pathogen-associated molecular patterns (PAMPs) that is distinct from adult blood cells.
Adiga V, Bindhu H, Ahmed A, Kumar NC, Tripathi H, D'Souza G, Dias M, Shivalingaiah S, Rao S, Shanti KN, Hawrylowicz C, Dwarkanath P, Vyakarnam A. Adiga V, et al. Among authors: dias m. Clin Exp Immunol. 2024 May 2:uxae034. doi: 10.1093/cei/uxae034. Online ahead of print. Clin Exp Immunol. 2024. PMID: 38695079
Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients.
Pradeep SP, Hoovina Venkatesh P, Manchala NR, Vayal Veedu A, Basavaraju RK, Selvasundari L, Ramakrishna M, Chandrakiran Y, Krishnamurthy V, Holigi S, Thomas T, Ross CR, Dias M, Satchidanandam V. Pradeep SP, et al. Among authors: dias m. Front Immunol. 2021 Jul 14;12:677874. doi: 10.3389/fimmu.2021.677874. eCollection 2021. Front Immunol. 2021. PMID: 34335578 Free PMC article.
Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences.
Sankaradoss A, Jagtap S, Nazir J, Moula SE, Modak A, Fialho J, Iyer M, Shastri JS, Dias M, Gadepalli R, Aggarwal A, Vedpathak M, Agrawal S, Pandit A, Nisheetha A, Kumar A, Bordoloi M, Shafi M, Shelar B, Balachandra SS, Damodar T, Masika MM, Mwaura P, Anzala O, Muthumani K, Sowdhamini R, Medigeshi GR, Roy R, Pattabiraman C, Krishna S, Sreekumar E. Sankaradoss A, et al. Among authors: dias m. Mol Ther. 2022 May 4;30(5):2058-2077. doi: 10.1016/j.ymthe.2022.01.013. Epub 2022 Jan 7. Mol Ther. 2022. PMID: 34999210 Free PMC article.
1,963 results